SCHEMBL6536256

SCHEMBL6536256

O=C(NCC1CCN(C(=O)O)CC1)c1ccc(O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.55
PKM P14618 1/20 0.55
TPSAB1 Q15661 4/20 0.54
F2 P00734 2/20 0.54
PLG P00747 2/20 0.54
PRSS1 P07477 2/20 0.54
PRSS2 P07478 2/20 0.54
PRSS3 P35030 2/20 0.54
TPSD1 Q9BZJ3 2/20 0.54
TPSG1 Q9NRR2 2/20 0.54
HDAC3 O15379 5/20 0.53
HDAC6 Q9UBN7 5/20 0.53
HDAC4 P56524 4/20 0.53
HDAC1 Q13547 4/20 0.53
HDAC7 Q8WUI4 4/20 0.53
HDAC2 Q92769 4/20 0.53
HDAC10 Q969S8 4/20 0.53
HDAC11 Q96DB2 4/20 0.53
HDAC8 Q9BY41 4/20 0.53
HDAC9 Q9UKV0 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3435082 0.87 KDM4E (0.54) KDM4EPKMTPSAB1F2PLG
SCHEMBL3123586 0.87 KDM4E (0.54) KDM4EPKMTPSAB1F2PLG
SCHEMBL4492779 0.85 MAPK14 (0.57) HDAC3HDAC6HDAC4HDAC1HDAC7
SCHEMBL5362915 0.81 HDAC6 (0.60) KDM4EPKMHDAC3HDAC6HDAC4
SCHEMBL5368103 0.81 TPSAB1 (0.71) KDM4EPKMTPSAB1F2PLG
SCHEMBL5371009 0.81 PKM (0.51) KDM4EPKMTPSAB1F2PLG
SCHEMBL5367904 0.81 ME2 (0.56) KDM4EPKMTPSAB1F2PLG
SCHEMBL8389571 0.80 HDAC6 (0.68) HDAC3HDAC6HDAC1HDAC2MEN1
SCHEMBL5371060 0.80 HDAC3 (0.82) HDAC3HDAC6HDAC4HDAC1HDAC7
SCHEMBL5364859 0.80 SIGMAR1 (0.52) KDM4EPKMHDAC3HDAC6HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399160-A4 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES MERCK & CO INC (US) 2004-08-25 EP disclosed
EP-1399160-A2 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES Merck & Co., Inc. (US) 2004-03-24 EP disclosed
WO-2002100352-A2 NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES MERCK & CO., INC. (US) 2002-12-19 WO disclosed